Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and albendazole

imatinib mesylate has been researched along with albendazole in 3 studies

Compound Research Comparison

Studies
(imatinib mesylate)		Trials
(imatinib mesylate)		Recent Studies (post-2010)
(imatinib mesylate)		Studies
(albendazole)		Trials
(albendazole)		Recent Studies (post-2010) (albendazole)
11,4779605,7734,9815392,033

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Jeon, J; Koh, YI; Ryang, DW; Won, EJ1
Alves, P; Bota, S; Constantino, C; Maia, R1

Other Studies

3 other study(ies) available for imatinib mesylate and albendazole

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy.
    The Korean journal of parasitology, 2015, Volume: 53, Issue:2

    Topics: Aged; Albendazole; Animals; Diabetes Mellitus, Type 2; Eosinophilia; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Steroids; Strongyloides stercoralis; Strongyloidiasis

2015
Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.
    BMJ case reports, 2019, Apr-29, Volume: 12, Issue:4

    Topics: Adrenal Cortex Hormones; Africa; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Bone Diseases; Child, Preschool; Drug Combinations; Female; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Ivermectin; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Rare Diseases; Receptor, Platelet-Derived Growth Factor alpha; Strongyloides stercoralis; Strongyloidiasis; Treatment Outcome

2019